Systematic Reviews
Copyright ©The Author(s) 2024.
World J Diabetes. Aug 15, 2024; 15(8): 1793-1801
Published online Aug 15, 2024. doi: 10.4239/wjd.v15.i8.1793
Figure 4
Figure 4 Teplizumab vs placebo. A: Pooled odds ratio (OR) of total adverse effects in teplizumab vs placebo; B: Pooled OR of gastrointestinal adverse effects in teplizumab vs placebo; C: OR of dermatological adverse effects in teplizumab vs placebo; D: OR of lymphopenia in teplizumab vs placebo.